A novel glycogen synthase kinase‐3 inhibitor 2‐methyl‐5‐(3‐{4‐[(S )‐methylsulfinyl]phenyl}‐1‐benzofuran‐5‐yl)‐1,3,4‐oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer’s disease [PDF]
Tomohiro Onishi +9 more
openalex +1 more source
Inhibition of Glycogen Synthase II with RNAi Prevents Liver Injury in Mouse Models of Glycogen Storage Diseases [PDF]
Natalie W. Pursell +19 more
openalex +1 more source
EXERCISE EFFECTS ON MUSCLE GLUCOSE UPTAKE AND INSULIN ACTION [PDF]
Derave, Wim
core +1 more source
In silico investigation of novel Plasmodium Falciparum glycogen synthase kinase (pfGSk3β) inhibitors for the treatment of malaria infection. [PDF]
Adebambo KF, Otify S.
europepmc +1 more source
Phosphorylations of serines 21/9 in glycogen synthase kinase 3α/β are dispensable for V600EBRAF-driven premalignant tumour development in the mouse intestine. [PDF]
Farahmand P +9 more
europepmc +1 more source
Retraction: Role of glycogen synthase kinase-3β and PPAR-γ on epithelial-to-mesenchymal transition in DSS-induced colorectal fibrosis. [PDF]
PLOS One Editors.
europepmc +1 more source
Glycogen Synthase Kinase 3 Is Essential for Intestinal Cell Niche and Digestive Function. [PDF]
Yang M +7 more
europepmc +1 more source

